Neurocrine Biosciences names Eiry W. Roberts chief medical officer, replacing Sanjay Keswani
NBIX•Neurocrine Biosciences named Eiry W. Roberts chief medical officer, effective immediately, and said Sanjay Keswani will leave under a mutual agreement.
1. Leadership change
Roberts previously served as the company’s chief medical officer from 2018 to 2025 and most recently acted as a strategic advisor. She spent 26 years at Eli Lilly, including as vice president of research and development.
